Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 8/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | TET2 | Q6N021 | 1/20 | 1.00 |
| ▸ | DOHH | Q9BU89 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.92 |
| ▸ | LMNA | P02545 | 1/20 | 0.92 |
| ▸ | GAA | P10253 | 1/20 | 0.92 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.92 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 7/20 | 0.40 |
| ▸ | CASP2 | P42575 | 1/20 | 0.38 |
| ▸ | KDM5A | P29375 | 1/20 | 0.37 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.37 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17109729 | 1.00 | KDM4A (1.00) | KDM4AHIF1ATET2DOHHKDM4E | |
| SCHEMBL13367139 | 1.00 | KDM4A (1.00) | KDM4AHIF1ATET2DOHHKDM4E | |
| SCHEMBL21051754 | 1.00 | KDM4A (1.00) | KDM4AHIF1ATET2DOHHKDM4E | |
| Deferoxamine SCHEMBL10498260 | 1.00 | KDM4A (1.00) | KDM4AHIF1ATET2DOHHKDM4E | |
| SCHEMBL19040665 | 1.00 | KDM4A (1.00) | KDM4AHIF1ATET2DOHHKDM4E | |
| SCHEMBL26511991 | 1.00 | KDM4A (1.00) | KDM4AHIF1ATET2DOHHKDM4E | |
| SCHEMBL17100575 | 1.00 | KDM4A (1.00) | KDM4AHIF1ATET2DOHHKDM4E | |
| Deferoxamine SCHEMBL20658962 | 0.99 | KDM4A (0.97) | KDM4AHIF1ATET2DOHHKDM4E | |
| Deferoxamine SCHEMBL21049242 | 0.99 | KDM4A (0.97) | KDM4AHIF1ATET2DOHHKDM4E | |
| Deferoxamine SCHEMBL20658960 | 0.99 | KDM4A (0.97) | KDM4AHIF1ATET2DOHHKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 30115 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144251-A1 | ANTIMICROBIAL NANOCLAYS COMPRISING CATIONIC ANTIMICROBIALS, METHOD OF PREPARATION AND USES THEREOF | POLYAMYNA NANOTECH INC. (CA) | 2026-05-28 | — | — | US | claimed |
| US-20260146046-A1 | BICYCLIC FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2026-05-28 | — | — | US | claimed |
| CN-122080099-A | Amphiphilic nicotinamide adenine dinucleotide conjugate, nano micelle and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026106498-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-21 | — | — | WO | claimed |
| WO-2026106998-A1 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR AND RELATED COMPOSITION AND METHOD OF USE | PURDUE RESEARCH FOUNDATION (US) | 2026-05-21 | — | — | WO | claimed |
| EP-3364967-B1 | FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2026-05-20 | — | — | EP | claimed |
| EP-4744486-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES. | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| EP-4744487-A1 | FLUID, METHODS OF PRODUCING FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| CN-121385294-B | Quantitative detection method for lead in trivalent ferromagnetism solid-phase masking agent and vegetable product | 海检检测(浙江)有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122031775-A | Preparation method of biological medicine acellular amniotic hydrogel | 桂林医科大学 | 2026-05-15 | — | — | CN | claimed |
| EP-0035765-B1 | A PHYSIOLOGICALLY ACTIVE SUBSTANCE-COMBINED COMPOUND AND ITS USE FOR THE PREPARATION OF A RADIOACTIVE METALLIC ELEMENT-LABELED COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1984-11-21 | — | — | EP | claimed |
| US-4474751-A | SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| EP-0101341-A1 | Process and device for the encapsulation in erythrocytes of at least one biologically active substance, in particular hemoglobin allosteric effectors, and erythrocytes so obtained | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1984-02-22 | — | — | EP | claimed |
| US-4425319-A | DEFEROXAMINE | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1984-01-10 | — | — | US | claimed |
| US-4419365-A | Method of treating Alzheimer's disease | CIBA-GEIGY CORPORATION (US) | 1983-12-06 | — | — | US | claimed |
| US-4397867-A | Treatment of arthritic complaints | CIBA-GEIGY CORPORATION (US) | 1983-08-09 | — | — | US | claimed |
| EP-0083129-A1 | Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments | Mallinckrodt Diagnostica (Holland) B.V. (NL) | 1983-07-06 | — | — | EP | claimed |
| EP-0068314-A1 | Treatment of arthritic complaints | CIBA-GEIGY AG (CH) | 1983-01-05 | — | — | EP | claimed |
| EP-0035765-A2 | A physiologically active substance-combined compound and its use for the preparation of a radioactive metallic element-labeled compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1981-09-16 | — | — | EP | claimed |
| US-3957435-A | FERRIC SPECIFIC CHELATING AGENT | MILES LABORATORIES, INC. (US) | 1976-05-18 | — | — | US | claimed |